The oncology therapeutics company increased its investment in research and development to $9.4 million this quarter.
Click here to view original post
Related Articles
ROCKY MOUNTAIN SPINE & SPORT OPENS OUTPATIENT CLINIC IN LITTLETON, COLO.
At 7987 S. Broadway LITTLETON, Colo., Jan. 10, 2023 /PRNewswire/ — Rocky Mountain Spine & Sport Physical Therapy opened a second Littleton outpatient clinic Monday at 7987 S. Broadway. The Littleton-Southpark clinic, as it is […]
Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting
SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be presented at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting, being held this […]
Cochlear announces 2024 winners of annual scholarships
The Graeme Clark, Anders Tjellström and Vocational Scholarships recognize exemplary leaders throughout the hearing loss community LONE TREE, Colo., Feb. 22, 2024 /PRNewswire/ — Eight outstanding Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® […]
